NCT07718854
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
Clinical trial condition
Recurrent Ovarian Clear Cell Adenocarcinoma
Explore clinical trials studying Recurrent Ovarian Clear Cell Adenocarcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
3 recruiting studies
Recurrent Ovarian Clear Cell Adenocarcinoma trial results
NCT05950464
- Conditions
- Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
- Locations
-
- Augusta University Medical Center Augusta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
NCT05231122
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT05920798
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +30 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, not recruiting
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02839707
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +33 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, not recruiting
Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
NCT04739800
- Conditions
- Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma, +47 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, not recruiting
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
NCT04092270
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +43 more
- Locations
-
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
Active, not recruiting
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
NCT03348631
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States